Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bichsel, Colette A ^a,b,c   Wang, Limei ^a,b   Froment, Laurène ^a,b   Berezowska, Sabina ^a   Müller, Stefan ^a   Dorn, Patrick ^a,b   Marti, Thomas M ^a,b   Peng, Ren Wang ^a,b   Geiser, Thomas ^a,b   Schmid, Ralph A ^a,b   Guenat, Olivier T ^a,b   Hall, Sean R R ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BIOLOGICAL MARKER; CD274 PROTEIN, HUMAN; EPITHELIAL CELL ADHESION MOLECULE; INTERLEUKIN 6; PROGRAMMED DEATH 1 LIGAND 1; THY 1 MEMBRANE GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BIOSYNTHESIS; CAPILLARY PERMEABILITY; GENETICS; HUMAN; LUNG TUMOR; MESENCHYMAL STEM CELL; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NON SMALL CELL LUNG CANCER; PATHOLOGY; PERICYTE; STROMA CELL;

5'-NUCLEOTIDASE; B7-H1 ANTIGEN; BIOMARKERS; CAPILLARY PERMEABILITY; CARCINOMA, NON-SMALL-CELL LUNG; EPITHELIAL CELL ADHESION MOLECULE; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MESENCHYMAL STEM CELLS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; STROMAL CELLS; THY-1 ANTIGENS; TRANSFORMING GROWTH FACTOR BETA;

EID: 85028940517     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-09928-1     Document Type: Article

References (46)

1. Otranto, M. et al. The role of the myofibroblast in tumor stroma remodeling. Cell Adhes. Migr. 6, 203-219 (2012).
2. Gonda, T. A., Varro, A., Wang, T. C. & Tycko, B. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy Semin. Cell Dev. Biol. 21, 2-10 (2010).
3. Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev. Cell 18, 884-901 (2010).
4. Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346-354 (2013).
5. Kidd, S. et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27, 2614-2623 (2009).
6. Hanahan, D. & Coussens, L. M. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell 21, 309-322 (2012).
7. Lin, S.-L., Kisseleva, T., Brenner, D. A. & Duffield, J. S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627 (2008).
8. Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97 (2010).
9. Weibel, E. R. On pericytes, particularly their existence on lung capillaries. Microvasc. Res. 8, 218-35 (1974).
10. Hung, C. et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188, 820-30 (2013).
11. Bagley, R. G. et al. Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvasc. Res. 71, 163-174 (2006).
12. Armulik, A., Genové, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215 (2011).
13. Diaz-Flores, L. et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 24, 909-969 (2009).
14. Raza, A., Franklin, M. J. & Dudek, A. Z. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am. J. Hematol. 85, 593-598 (2010).
15. Jain, R. K. Molecular regulation of vessel maturation. Nat. Med. 9, 685-93 (2003).
16. Morikawa, S. et al. Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors. Am. J. Pathol. 160, 985-1000 (2002).
17. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Seminars in oncology 29, 15-18 (2002).
18. Keskin, D. et al. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. Cell Rep. 10, 1066-81 (2015).
19. Hong, J. et al. Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells. J Natl Cancer Inst. 107, djv209 (2015).
20. Bichsel, C. A., Hall, S. R. R., Schmid, R. A., Guenat, O. T. & Geiser, T. Primary human lung pericytes support and stabilize in vitro perfusable microvessels. Tissue Eng. Part A 21, 2166-2176 (2015).
21. Armulik, A., Abramsson, A. & Betsholtz, C. Endothelial/pericyte interactions. Circ. Res. 97, 512-23 (2005).
22. Bremnes, R. M. et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J. Thorac. Oncol. 6, 209-217 (2011).
23. High, F. A. et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci USA 105, 1955-1959 (2008).
24. Boscolo, E. et al. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 31, 2181-2192 (2011).
25. Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro. Oncol. 7, 452-464 (2005).
26. Mcdonald, D. M. & Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res. 62, 5381-5 (2002).
27. Li, L. et al. Metformin sensitizes EGFR-TKI-Resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin. Cancer Res. 20, 2714-2726 (2014).
28. Caetano, M. S. et al. IL-6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras mutant lung cancer. Cancer Res. 76, 3189-99 (2016).
29. Schafer, Z. T. & Brugge, J. S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117, 3660-3663 (2007).
30. Ochoa, C. D., Wu, S. & Stevens, T. New Developments in Lung Endothelial Heterogeneity: von Willebrand factor, P-selectin, and the Weibel-Palade Body. Semin Thromb Hemost 36, 301-308 (2010).
31. Sun, J.-M. et al. Prognostic significance of programmed cell death ligand 1 in patients with non-small-cell lung cancer: A large cohort study of surgically resected cases. J. Thorac. Oncol. 11, 1003-11 (2016).
32. Passiglia, F. et al. PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis. Oncotarget 7, 19738-47 (2016).
33. Gopinathan, G. et al. Interleukin-6 stimulates defective angiogenesis. Cancer Res. 75, 3098-3107 (2015).
34. Waugh, D. J. J. & Wilson, C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14, 6735-6741 (2008).
35. Li, A., Dubey, S., Varney, M. L., Bhavana, J. & Singh, R. K. IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis. J Immunol. 170, 3369-3376 (2003).
36. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-74 (2011).
37. Bianco, P. et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35-42 (2013).
38. LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047-53 (2013).
39. Rock, J. S. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 108, E1475-83 (2011).
40. Arina, A. et al. Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci USA 113, E7551-6 (2016).
41. Hosake, K. et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci USA 113, E5618-27 (2016).
42. Caplan, A. I. All MSCs Are Pericytes Cell Stem Cell 3, 229-230 (2008).
43. Procopio, M. G. et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat. Cell Biol. 17, 1193-204 (2015).
44. Li, P. et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 25, 588-603 (2015).
45. Tung, J. W. et al. Modern flow cytometry: a practical approach. Clin. Lab. Med. 27, 453-468 (2007).
46. Herzenberg, L. A., Tung, J., Moore, W. A., Herzenberg, L. A. & Parks, D. R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681-685 (2006).